Bengaluru-based biotech giant sees investor confidence grow following FDA’s favorable inspection reports Syngene International, a leading global contract research and manufacturing organization (CRMO), experienced a sharp surge in its share price following two important positive updates from the U.S. Food and Drug Administration (FDA). These developments, which relate to inspections conducted at Syngene’s Bengaluru facilities, have fueled investor optimism and …
By Miles Pennington, Senior Correspondent On June 14, 2025, Lemonade Day Northern …
By Miles Pennington, Senior Correspondent The Global Entrepreneurship Monitor (GEM) 2024–2025 United …
By Rachel Kim, Senior Correspondent Entrepreneurial activity in the United States has …
Bay Area businesswoman and mother, Jennifer Heller, is revolutionizing the way families …
The United States has achieved a significant milestone in 2025, with Total …
Ever felt unfulfilled and uncertain in your business, despite outward success? Maybe …
By Heather Stone, Senior Correspondent The United States has witnessed a remarkable …
Superior Speed Co. is a company dedicated to advancing American grassroots racing …
Thousands of innovators from over 200 countries converge in Indiana as the …
BizWeekly, your go-to source for the latest and most insightful business news. We are dedicated to delivering timely updates, expert analyses, and comprehensive coverage of the ever-evolving business world.
Copyright ©️ 2025 BizWeekly | All rights reserved.
